BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Montagnana M, Danese E, Lippi G. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time? Clin Chim Acta. 2015;445:161-166. [PMID: 25840050 DOI: 10.1016/j.cca.2015.03.031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma H, Wang Y, Wu D, Zhang Y, Gao J, Ren X, Du B, Wei Q. A Novel Controlled Release Immunosensor based on Benzimidazole Functionalized SiO2 and Cyclodextrin Functionalized Gold. Sci Rep 2016;6:19797. [PMID: 26791418 DOI: 10.1038/srep19797] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
2 Unić A, Derek L, Duvnjak M, Patrlj L, Rakić M, Kujundžić M, Renjić V, Štoković N, Dinjar P, Jukic A, Grgurević I. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis. Ann Clin Biochem 2018;55:355-62. [DOI: 10.1177/0004563217726808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
3 Shrestha R, Prithviraj P, Anaka M, Bridle KR, Crawford DHG, Dhungel B, Steel JC, Jayachandran A. Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma. Front Oncol. 2018;8:269. [PMID: 30057891 DOI: 10.3389/fonc.2018.00269] [Cited by in Crossref: 38] [Cited by in F6Publishing: 46] [Article Influence: 9.5] [Reference Citation Analysis]
4 Yu J, Wang ZJ, Chen LH, Dong WZ. Diagnostic value of serum squamous cell carcinoma antigen for hepatocellular carcinoma: a systematic review and meta-analysis. Scand J Clin Lab Invest 2017;77:8-14. [PMID: 27762143 DOI: 10.1080/00365513.2016.1238504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Balasso A, Salmaso S, Pontisso P, Rosato A, Quarta S, Malfanti A, Mastrotto F, Caliceti P. Re-programming pullulan for targeting and controlled release of doxorubicin to the hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences 2017;103:104-15. [DOI: 10.1016/j.ejps.2017.02.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
6 Gupta R, Kleinjans J, Caiment F. Identifying novel transcript biomarkers for hepatocellular carcinoma (HCC) using RNA-Seq datasets and machine learning. BMC Cancer 2021;21:962. [PMID: 34445986 DOI: 10.1186/s12885-021-08704-9] [Reference Citation Analysis]
7 Martini A, Gallotta A, Pontisso P, Fassina G. Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World J Hepatol 2015; 7(29): 2913-2919 [PMID: 26689503 DOI: 10.4254/wjh.v7.i29.2913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
8 Dipalo M, Gnocchi C, Aloe R, Lippi G. Analytical assessment of the novel Maglumi squamous cell carcinoma antigen (SCCA) immunoluminometric assay. Ann Transl Med 2015;3:351. [PMID: 26807406 DOI: 10.3978/j.issn.2305-5839.2015.12.34] [Cited by in F6Publishing: 1] [Reference Citation Analysis]